Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04867538
Status:
COMPLETED
Last Update Posted:
2021-04-30
First Post:
2021-04-27
Brief Title:
The Cholelithiasis in Adults With Short Bowel Syndrome
Sponsor:
Jinling Hospital China
Organization:
Jinling Hospital China
Study Overview
Official Title:
Prevalence Risk Factors and Complications of Cholelithiasis in Adults With Short Bowel Syndrome
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Short-term studies have shown that patients with short bowel syndrome SBS often develop cholestasis or cholelithiasis In this retrospective cohort study we aimed to define the incidence risk factors and clinical consequences of cholelithiasis in adults with SBS over an extended time period
Detailed Description:
However only limited data are available regarding cholelithiasis in patients with SBS The prevalence of cholelithiasis in patients with SBS has been reported only in two studies Furthermore few studies have focused on identifying the risk factors for cholelithiasis in patients with SBS Considering the marked improvements in medical care and nutrition support during the last 2 decades the current incidence and risk factors for cholelithiasis in patients with SBS are unknown
The aim of the current study was to provide comprehensive longitudinal and long-term data on the incidence of symptomatic and asymptomatic cholelithiasis in a cohort of patients with SBS in order to identify the prevalence risk factors and clinical consequences of cholelithiasis in patients with SBS to aid in the development of protective interventions
The aim of the current study was to provide comprehensive longitudinal and long-term data on the incidence of symptomatic and asymptomatic cholelithiasis in a cohort of patients with SBS in order to identify the prevalence risk factors and clinical consequences of cholelithiasis in patients with SBS to aid in the development of protective interventions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None